SureTrader
Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

There is a "buyout rumor" circulating right now,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Superfly15 Member Profile
 
Followed By 40
Posts 2,771
Boards Moderated 0
Alias Born 03/23/10
160x600 placeholder
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/9/2016 4:20:28 PM
CEL-SCI Corporation Reports First Quarter Fiscal 2016 Financial Results "Business Wire" - 2/9/2016 4:20:00 PM
CEL-SCI To Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference "Business Wire" - 2/8/2016 9:00:00 AM
CEL-SCI to Present at 18th Annual BIO CEO & Investor Conference "Business Wire" - 2/3/2016 9:00:00 AM
CEL-SCI Reports Monthly Patient Enrollment in January for Its Phase 3 Head and Neck Cancer Trial "Business Wire" - 2/1/2016 10:00:00 AM
CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine "Business Wire" - 1/25/2016 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/15/2016 4:56:54 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 1/15/2016 4:49:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/15/2016 4:31:54 PM
CEL-SCI Corporation to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference "Business Wire" - 1/14/2016 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/14/2016 8:50:23 AM
CEL-SCI Corporation Summarizes Significant Accomplishments in 2015 and Positive Momentum for 2016 "Business Wire" - 1/8/2016 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/5/2016 11:17:29 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/5/2016 11:15:17 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/5/2016 11:12:16 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/5/2016 11:09:32 AM
CEL-SCI Reports Record Year for Patient Enrollment with 75% Increase in Its Global Phase 3 Head and Neck Cancer Trial "Business Wire" - 1/5/2016 8:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 12/11/2015 4:36:45 PM
CEL-SCI Reports Fiscal 2015 Financial Results and Clinical & Corporate Developments "Business Wire" - 12/11/2015 4:36:00 PM
CEL-SCI’s CEO Presentation Available on Company Website "Business Wire" - 12/4/2015 1:17:00 PM
CEL-SCI Reports Monthly Patient Enrollment in November for Its Phase 3 Head and Neck Cancer Trial "Business Wire" - 12/1/2015 10:30:00 AM
CEL-SCI is Granted a New European Patent on Its Phase 3 Investigational Cancer Immunotherapy Multikine "Business Wire" - 11/17/2015 9:56:00 AM
CEL-SCI’s Rheumatoid Arthritis Vaccine Selected for Commercialization & Program Niche Analysis Plan by U.S. National Instit... "Business Wire" - 11/4/2015 10:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/2/2015 4:31:38 PM
CEL-SCI Reports Record Monthly Patient Enrollment in October for Its Phase 3 Head and Neck Cancer Trial "Business Wire" - 11/2/2015 8:15:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist